Robbins A S
Department of Public Health and Preventive Medicine, Loma Linda University, California 92350.
West J Med. 1993 Jan;158(1):36-9.
Controversy in medicine is inevitable, but it becomes problematic when the issue is a serious public health problem requiring a clear plan of action. In recent years measles has made a major resurgence in this country, with provisional figures showing 89 measles-related deaths in 1990. The Immunization Practices Advisory Committee of the US Public Health Service, the Committee on Infectious Diseases of the American Academy of Pediatrics, and the US Preventive Services Task Force have all issued recommendations for measles immunization. Most of these recommendations are in agreement, but they conflict on the age at which vaccination should be given and the number of doses. To assist physicians in disentangling this complex web, I review the history of measles immunization in the United States and give the rationale for particular positions wherein the groups disagree. I describe protocols for routine vaccinations, endemic areas, outbreak control, colleges and universities, and international travel.
医学领域存在争议在所难免,但当问题涉及严重的公共卫生问题且需要明确的行动计划时,争议就会引发问题。近年来,麻疹在该国大幅卷土重来,初步数据显示1990年有89例与麻疹相关的死亡病例。美国公共卫生服务部免疫实践咨询委员会、美国儿科学会传染病委员会以及美国预防服务工作组均已发布了麻疹免疫接种建议。这些建议大多相互一致,但在接种疫苗的年龄和剂量数量上存在冲突。为帮助医生理清这一复杂的局面,我回顾了美国麻疹免疫接种的历史,并给出各团体存在分歧的特定立场的理论依据。我描述了常规疫苗接种、流行地区、疫情控制、高校以及国际旅行的方案。